doi:10.3746/pnf.2019.24.2.103
Additionally, the low bioavailability of PCs, primarily due to poor gastrointestinal absorption, poses challenges for clinical application
Collage by Diana Connolly Want more information about clinical care
Key clinical findings include: Gallbladder events were observed throughout the treatment period The FDA recommends informing patients of characteristic symptoms of cholelithiasis and cholecystitis If cholelithiasis is suspected, appropriate clinical evaluation and treatment are indicated Patients generally responded to standard medical or surgical management Clinicians should interpret these data within the broader context of tirzepatide's substantial metabolic benefits, including significant improvements in glycemic control, cardiovascular risk factors, and weight-related comorbidities, while maintaining appropriate vigilance for gallbladder complications
Try not to let worry take away from the positive step you are taking for your health
It could explain why some patients notice a hollow, saggy, and/or dull look when they go on a GLP-1
